Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study seeks to uncover why some liver patients develop cancer

NCT ID NCT05623150

First seen Apr 28, 2026 · Last updated Jun 16, 2026 · Updated 13 times

Summary

This study aims to find out why some people with fatty liver disease or alcohol-related liver disease develop liver cancer. Researchers will look at metabolic factors, immune system responses, and imaging data from 710 participants. The goal is to identify early warning signs, especially in patients without cirrhosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Batiment Archimed 151, route de Saint Antoine de Ginestière

    RECRUITING

    Nice, France

Conditions

The condition(s) this trial relates to.

alcoholic liver disease cirrhosis of liver hepatocellular carcinoma metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.